[用于创伤后应激障碍的MDMA辅助治疗]
Helga Thorarinsdottir1, Berglind Gudmundsdottir2, Engilbert Sigurdsson2
1Mental Health Services Landspitali University Hospital, Iceland.
Laeknabladid
|May 7, 2024
概括
在治疗创伤后应激障碍 (PTSD) 方面,MDMA辅助疗法显示出前景. 这种新的方法结合了药物治疗和心理治疗,以减少PTSD患者的痛苦和改善结果.
科学领域:
- 精神病学是一个精神病学.
- 心理药理学 心理药理学
- 创伤研究 创伤研究
背景情况:
- 创伤后应激障碍 (PTSD) 是一个重要的未满足的医疗需求.
- 目前的PTSD治疗方法在有效性和患者坚持治疗方面存在局限性.
- 现在MDMA (3,4-methylenedioxymethamphetamine) 正在作为一种新型治疗药物进行研究.
研究的目的:
- 审查关于MDMA的当前知识及其在PTSD的MDMA辅助心理治疗中的应用.
- 综合最近关于MDMA在PTSD治疗中的疗效和安全性的研究结果.
- 突出进一步研究和监管评估的需要.
主要方法:
- 在PubMed,科学网络和谷歌学者中进行了全面的文献搜索.
- 来自已识别的文章的引用被审查以收集相关数据.
- 该审查综合了关于MDMA辅助治疗PTSD的协议和结果的信息.
主要成果:
- 用MDMA辅助的心理治疗包括与经过培训的治疗师进行准备,剂量和整合性治疗.
- 这种治疗模式旨在减少创伤处理期间的心理痛苦,促进治疗.
- 最近的研究表明,MDMA辅助心理治疗有效地减少了PTSD症状,并且被很好地容忍.
结论:
- 用MDMA辅助的心理治疗显示出作为PTSD新且有效的治疗方法的潜力.
- 进一步的严格研究对于MDMA辅助疗法的监管批准至关重要.
- 需要与现有的PTSD治疗方法进行比较研究,以确定其在临床实践中的地位.
相关概念视频
01:27Post-traumatic Stress Disorder
32
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
32
01:30Electroconvulsive Therapy
36
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
36
01:23Antidepressant Drugs: MAOIs and Other Agents
226
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
226
01:22Alzheimer's Disease: Treatment
181
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
181